167 related articles for article (PubMed ID: 1314113)
41. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract.
Kobashi Y; Nakamura S; Sasajima Y; Koshikawa T; Yatabe Y; Kitoh K; Mori S; Ueda R; Yamabe H; Suchi T
Histopathology; 1996 Feb; 28(2):111-20. PubMed ID: 8834518
[TBL] [Abstract][Full Text] [Related]
42. Malignant granular lymphoproliferation after Epstein-Barr virus infection: partial immunologic reconstitution with interleukin-2.
Aronson FR; Dempsey RA; Allegretta M; André-Schwartz J; Poldre PA; Hillyer CD; Parkinson DR; Rudders RA; Schwartz RS; Mier JW
Am J Hematol; 1987 Aug; 25(4):427-39. PubMed ID: 3039837
[TBL] [Abstract][Full Text] [Related]
43. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection.
Imai S; Sugiura M; Oikawa O; Koizumi S; Hirao M; Kimura H; Hayashibara H; Terai N; Tsutsumi H; Oda T; Chiba S; Osato T
Blood; 1996 Feb; 87(4):1446-57. PubMed ID: 8608235
[TBL] [Abstract][Full Text] [Related]
44. Aggressive natural killer cell lymphoproliferative disorder associated with Epstein-Barr viral RNA.
Hirose Y; Masaki Y; Yoshioka R; Takiguchi T
Am J Hematol; 1997 Apr; 54(4):314-20. PubMed ID: 9092688
[TBL] [Abstract][Full Text] [Related]
45. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
46. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
Ohga S; Ishimura M; Yoshimoto G; Miyamoto T; Takada H; Tanaka T; Ohshima K; Ogawa Y; Imadome K; Abe Y; Akashi K; Hara T
J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
[TBL] [Abstract][Full Text] [Related]
47. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
[TBL] [Abstract][Full Text] [Related]
48. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.
Mannick JB; Cohen JI; Birkenbach M; Marchini A; Kieff E
J Virol; 1991 Dec; 65(12):6826-37. PubMed ID: 1658376
[TBL] [Abstract][Full Text] [Related]
49. Intestinal T-cell and natural killer-cell lymphomas in Taiwan with special emphasis on 2 distinct cellular types: natural killer-like cytotoxic T cell and true natural killer cell.
Tung CL; Hsieh PP; Chang JH; Chen RS; Chen YJ; Wang JS
Hum Pathol; 2008 Jul; 39(7):1018-25. PubMed ID: 18482744
[TBL] [Abstract][Full Text] [Related]
50. Restrictions upon Epstein-Barr virus infection of the leukemic cell are demonstrated in patients with hairy cell leukemia.
Sairenji T; Reisert PS; Spiro RC; Mulder C; Humphreys RE
Hematol Oncol; 1983; 1(3):251-62. PubMed ID: 6329936
[TBL] [Abstract][Full Text] [Related]
51. Quantitative analysis of cell-free Epstein-Barr virus DNA in the plasma of patients with peripheral T-cell and NK-cell lymphomas and peripheral T-cell proliferative diseases.
Suwiwat S; Pradutkanchana J; Ishida T; Mitarnun W
J Clin Virol; 2007 Dec; 40(4):277-83. PubMed ID: 17996493
[TBL] [Abstract][Full Text] [Related]
52. Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens.
Ambinder RF; Lambe BC; Mann RB; Hayward SD; Zehnbauer BA; Burns WS; Charache P
Mol Cell Probes; 1990 Oct; 4(5):397-407. PubMed ID: 2177846
[TBL] [Abstract][Full Text] [Related]
53. Absence of a reservoir of Epstein-Barr virus (EBV) in normal tongue epithelium.
Miller DR; Heard PL; Cagle MP; DiMaio D; Ench Y; Morrison DG; Eagan PA; Gulley ML; Jenson HB; Moyer MP
J Oral Pathol Med; 1994 Apr; 23(4):156-60. PubMed ID: 8046652
[TBL] [Abstract][Full Text] [Related]
54. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
55. EBV-NK cells interactions and lymphoproliferative disorders.
Kanegane H; Yachie A; Miyawaki T; Tosato G
Leuk Lymphoma; 1998 May; 29(5-6):491-8. PubMed ID: 9643562
[TBL] [Abstract][Full Text] [Related]
56. Detection of Epstein-Barr virus by PCR analyses in lymphoproliferative disease of granular lymphocytes.
Pellenz M; Zambello R; Semenzato G; Loughran TP
Leuk Lymphoma; 1996 Oct; 23(3-4):371-4. PubMed ID: 9031119
[TBL] [Abstract][Full Text] [Related]
57. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
Masucci MG; Contreras-Salazar B; Ragnar E; Falk K; Minarovits J; Ernberg I; Klein G
J Virol; 1989 Jul; 63(7):3135-41. PubMed ID: 2470924
[TBL] [Abstract][Full Text] [Related]
58. Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphoma.
Kon S; Sato T; Onodera K; Satoh M; Kikuchi K; Imai S; Osato T
Pathol Res Pract; 1993 Dec; 189(10):1137-44. PubMed ID: 8183733
[TBL] [Abstract][Full Text] [Related]
59. Primary immune responses by cord blood CD4(+) T cells and NK cells inhibit Epstein-Barr virus B-cell transformation in vitro.
Wilson AD; Morgan AJ
J Virol; 2002 May; 76(10):5071-81. PubMed ID: 11967323
[TBL] [Abstract][Full Text] [Related]
60. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
